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Measles elimination in Europe is in crisis. More than 80,000 confirmed cases 
were reported in 2018 in the 53 countries of the WHO European Region, the 
highest for 20 years. Fourteen countries in the region reported more than 500 
confirmed cases, including four previously deemed to have eliminated 
measles (Greece, Albania, Israel and the United Kingdom), that is interrupted 
transmission for three years. New strategies are urgently needed to put 
measles elimination in Europe back on track.  
 
In theory, controlling measles should be straightforward. Two doses of the 
MMR (measles-mumps-rubella) vaccine provide highly efficacious long-lasting 
protection. Yet in practice, achieving elimination has proven challenging. One 
of the most contagious diseases, measles can strike susceptible pockets even 
if national-level vaccination coverage is high. While asserting elimination 
status for individual nations may serve as a motivational tool, countries can 
experience large outbreaks even after several years of interrupted 
transmission. Countries such as Greece, Germany and Kyrgyzstan reported 
consistently high MMR uptake over the past decade but are still experiencing 
outbreaks. Moreover, outbreaks do not occur in isolation: they traverse 
country borders, sometimes lasting years and affecting different countries at 
different times​1​. 
 
In the light of these issues, there is a need to link efforts across the continent. 
The Pan-American Health Organisation interrupted measles transmission in 
the early 2000s through combined strategies including high routine 
immunisation, catch-up campaigns during periods of low transmission and 
follow-up campaigns ensuring high levels of immunity at the age of school 
entry, all applied uniformly across the Americas. Applying a similar joined-up 
approach in Europe would serve the dual purpose of increasing immunity in 
the general population while reducing the chance of imported cases reaching 
susceptible pockets. 
 
Epidemiological investigation would also benefit from combined efforts. 
Linking genetic and case data to better understand chains of transmission has 
proven successful for other diseases and may reveal the interconnectivity of 
measles across Europe​2​. Subnational seroprevalence studies could be used 
to better identify pockets of susceptibles​3​. Improved vaccine supply, advocacy 
and communication to population groups found to be most at risk could help 
increase immunity to the levels required​4​. ​Such efforts would come at a 
fraction of the cost of responding to outbreaks​5​. The Americas have shown 
that elimination of measles is feasible through a combination of political 
willpower, targeted interventions and concerted effort. If Europe can sustain a 
similar approach, it may still follow suit.  
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